Clinical Trials Browser

Phase 2 × Hizentra × 1 year × Clear all

NCT06976476 2026-03-11

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Phase 2 Recruiting

Agammaglobulinemia, Multiple Myeloma, Common Variable Immunodeficiency

NCT04728425 2025-04-27

MG_SCIG

Phase 2 Completed

Myasthenia Gravis